Gene · 4157
Papers3,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synchronous Melanoma: Definition, Prognosis, and Implications. A Comprehensive Review of Literature. | Plast Reconstr Surg Glob Open | 2023 | 37711724 | PubTator, text mining | PubMed |
| Predictors of correct recall of genetic risk information among Hispanic individuals in Florida and Puerto Rico. | Patient Educ Couns | 2023 | 37708699 | PubTator, text mining | PubMed |
| Sustained pigmentation causes DNA damage and invokes translesion polymerase Polκ for repair in melanocytes. | Nucleic Acids Res | 2023 | 37697436 | PubTator, text mining | PubMed |
Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland. | Int J Mol Sci | 2023 | 37685988 | PubTator, text mining | PubMed |
| Use of whole exome sequencing for identification of genetic variants related to Growth Hormone Deficiency and Short Stature: A Family-Based Study. | Pak J Med Sci | 2023 | 37680843 | PubTator, text mining | PubMed |
| MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression. | NPJ Precis Oncol | 2023 | 37679505 | PubTator, text mining | PubMed |
| Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease. | J Ocul Pharmacol Ther | 2023 | 37677000 | PubTator, text mining | PubMed |
| Translational research updates in female health anesthesiology: a narrative review. | Ann Transl Med | 2023 | 37675293 | PubTator, text mining | PubMed |
| A gel-forming α-MSH analog promotes lasting melanogenesis. | Eur J Pharmacol | 2023 | 37673364 | PubTator, text mining | PubMed |
| Hyperpigmentation in an Elderly Patient with Atopic Dermatitis: A Quiz. | Acta Derm Venereol | 2023 | 37671778 | PubTator, text mining | PubMed |
| Editorial: Tumor adaptation to cellular stresses: mechanisms, biomarkers and therapeutic opportunities. | Front Med (Lausanne) | 2023 | 37663659 | PubTator, text mining | PubMed |
| Obesity and thinness: insights from genetics. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37661743 | PubTator, text mining | PubMed |
| Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities. | Biochim Biophys Acta Rev Cancer | 2023 | 37657683 | PubTator, text mining | PubMed |
| TINF2 is a major susceptibility gene in Danish patients with multiple primary melanoma. | HGG Adv | 2023 | 37646013 | PubTator, text mining | PubMed |
| Lipocalin 2 receptors: facts, fictions, and myths. | Front Immunol | 2023 | 37638032 | PubTator, text mining | PubMed |
| Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report. | Medicina (Kaunas) | 2023 | 37629650 | PubTator, text mining | PubMed |
| Combine with RNA-seq Reveals the Effect of Melatonin in the Synthesis of Melanin in Primary Melanocytes of Silky Fowls Black-Bone Chicken. | Genes (Basel) | 2023 | 37628699 | PubTator, text mining | PubMed |
| Forensic DNA Phenotyping: Genes and Genetic Variants for Eye Color Prediction. | Genes (Basel) | 2023 | 37628655 | PubTator, text mining | PubMed |
| BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. | Cancers (Basel) | 2023 | 37627054 | PubTator, text mining | PubMed |
| High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium. | J Eur Acad Dermatol Venereol | 2023 | 37611275 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4157/papers?page=15